Funding Opportunities

Our consortium does not currently have fellowship or grant funding opportunities available. Previous opportunities are listed below.

ARISEN Early-Stage Investigator Research Grant

Opportunity Type: Education and Career Development

Goal: To reduce the barrier to entry and facilitate their conduct of rare disease research, the ARISEN Early-Stage Investigator (ESI) Pilot Research Award invites applications from ESIs for pilot research projects that accelerate clinical research in rare diseases aligned with the consortium’s mission, including autoimmune encephalitis, Rasmussen syndrome, and new onset refractory status epilepticus (NORSE), including its subtype with prior fever, Febrile Infection-Related Epilepsy Syndrome (FIRES).

Sponsor: Autoimmunity, Rasmussen’s, Inflammation & Status Epilepticus research Network (ARISEN)

Eligibility Criteria: The PI must hold an MD, PhD, MD/PhD, DO, RN or more advanced, PharmD, DDS, DVM, or equivalent, be a faculty member at U.S.-based academic institution, and be eligible to serve as PI on an extramural grant.

Letter of Intent Due Date: 2026-11-13

Application Due Date: 2027-02-17

Term: 12 months

ARISEN Pilot Research Grant

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Autoimmunity, Rasmussen’s, Inflammation & Status Epilepticus research Network (ARISEN) invites applications for pilot research projects that accelerate clinical research in rare diseases aligned with the consortium’s mission. ARISEN includes autoimmune encephalitis, Rasmussen syndrome, and new onset refractory status epilepticus (NORSE), including its subtype with prior fever, Febrile Infection-Related Epilepsy Syndrome (FIRES).

Sponsor: Autoimmunity, Rasmussen’s, Inflammation & Status Epilepticus research Network (ARISEN)

Eligibility Criteria: The PI must hold an MD, PhD, MD/PhD, DO, RN or more advanced, PharmD, DDS, DVM, or equivalent and be a faculty member at U.S.-based academic institution.

Letter of Intent Due Date: 2026-11-13

Application Due Date: 2027-02-15

Term: 12 months